Home > News > Profiting From His Inner Geek
November 2nd, 2007
Profiting From His Inner Geek
At least that's the hope, but others are not as sanguine. Jurvetson has been an especially visible booster of nanotechnology, the science of fabricating new products at the atomic and molecular levels. Among other things, he has spoken on panels, gone to Washington to lobby for research funds, and talked up the field's potential in the press. His company has also invested approximately $100 million in 30 nanotech-related companies. But so far, nanotech remains an area with potential only, with no hugely profitable nanotechnology firms having been started yet.
"To me, he has become Mr. Nanotech," says Lawrence Aragon, editor in chief of Venture Capital Journal, a trade publication, of Jurvetson. "If there's a big winner in there, he will be totally validated. But that's the trick with V.C. You can be right about a technology, and your timing could be completely wrong."
Silicon Catalyst Announces Partnership With imec to Support Semiconductor Start-Ups February 23rd, 2015
Ligar secures investment from Wallace Corporation to commercialise polymers that pick out good and bad molecules: Ground-breaking science innovation removes molecules in the wrong place from liquids February 15th, 2015
Harris & Harris Group Portfolio Company D-Wave Systems Raises an Additional $29 Million (CAD), Closing 2014 Financing at $62 Million (CAD) February 2nd, 2015
Ref signals deep impact as EPSRC announces £30 million for impact acceleration accounts (IAA) January 21st, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Moving molecule writes letters: Caging of molecules allows investigation of equilibrium thermodynamics February 27th, 2015
Untangling DNA with a droplet of water, a pipet and a polymer: With the 'rolling droplet technique,' a DNA-injected water droplet rolls like a ball over a platelet, sticking the DNA to the plate surface February 27th, 2015
Real-time observation of bond formation by using femtosecond X-ray liquidography February 26th, 2015
Graphene shows potential as novel anti-cancer therapeutic strategy: University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells February 26th, 2015